Latest filing published 13 May 2011 for Valeant Pharmaceuticals International, Inc., €862k.
Insider track record
No signal scores available.
Mark Andrew Durham: trading record in brief
This profile gathers the share dealings of Mark Andrew Durham across 2 companies, led by Valeant Pharmaceuticals International, Inc. and Bausch Health Companies Inc. Between 20 August 2010 and 11 May 2011, the trades on record add up to 7 filings.
No open-market purchase appears, only 2 sales worth €2.9M. Outside the open market, there are 1 share grant and 4 option exercises. So far in 2011, the count stands at no purchases and 1 sale.
Most recently, on 13 May 2011, the filings show an option exercise worth €862k in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Andrew Durham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares@ US$24.50Common Stock, no par valueSEC:0000885590-11-000025:0
- 50,000 shares@ US$52.17Common Stock, no par valueSEC:0000885590-11-000025:1
- 102,658 shares0Common Shares, no par valueSEC:0001477126-10-000004:0
- 46,628 shares@ US$26.12Common Shares, no par valueSEC:0001477126-10-000004:1
- 10,000 shares@ US$17.00Common Stock, no par valueSEC:0000885590-10-000034:0
- 50,000 shares@ US$17.00Common Stock, no par valueSEC:0000885590-10-000034:1
- 60,000 shares@ US$22.26Common Stock, no par valueSEC:0000885590-10-000034:2
7 of 7 declarations
